English

MEMORY PHARMACEUTICALS CORP

EDGAR

Quarterly report (10-Q) · filed 2008-11-14

21 filing records in this dataset, filed from 2004-05-20 to 2008-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.34 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 4339000 USD Source

Operating margin

-190.32%

2008-09-30 · %

Exact inputs and evidence

Operating Income: -8258000 USD Source
Revenue: 4339000 USD Source

Operating cash flow

-8.71 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -26212000 USD Source
Operating Cash Flow: -17502000 USD Source

Free cash flow

-8.71 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -26212000 USD Source
Operating Cash Flow: -17502000 USD Source
Capital Expenditure: 41000 USD Source
Capital Expenditure: 38000 USD Source

Cash and cash equivalents: 14 million USD 2008-09-30 Source
Exact value

14024000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

7.11 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Revenue: 11519000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 10444000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 752000 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 947000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 4339000 USD · 2008-07-01 – 2008-09-30 Source

Net income

-44.3 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Net income: -35285000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -25729000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -13445000 USD · 2008-01-01 – 2008-03-31 Source
Net income: -12406000 USD · 2008-04-01 – 2008-06-30 Source
Net income: -8940000 USD · 2008-07-01 – 2008-09-30 Source

Operating cash flow

-35.1 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: -33993000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -25125000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -10615000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -17502000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -10615000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -26212000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -17502000 USD · 2008-01-01 – 2008-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-14.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2007-12-31
Operating income: 6 of 11 periods available· newest 2007-12-31
Net income: 6 of 11 periods available· newest 2007-12-31
Operating cash flow: 6 of 11 periods available· newest 2007-12-31
Capital expenditure: 6 of 11 periods available· newest 2007-12-31
Total assets: 5 of 11 periods available· newest 2007-12-31
Total liabilities: 5 of 11 periods available· newest 2007-12-31
Current assets: 5 of 11 periods available· newest 2007-12-31
Current liabilities: 5 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+23.6%

Prior period

USD 9.32 million

2006-01-01 – 2006-12-31
Current period

USD 11.52 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

11519000 − 9322000 = 2197000 USD

9322000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
11519000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Year-over-year change in Revenue: 2197000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 11519000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#12189 Input fundies:Revenue: 9322000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#12189
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.18 million

Prior period

−USD 31.11 million

2006-01-01 – 2006-12-31
Current period

−USD 35.29 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-35285000 − -31107000 = -4178000 USD

-31107000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-35285000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Year-over-year change in Net income: -4178000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -35285000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16212 Input fundies:NetIncome: -31107000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16212
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 12.12 million

Prior period

−USD 21.88 million

2006-01-01 – 2006-12-31
Current period

−USD 33.99 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-33993000 − -21878000 = -12115000 USD

-21878000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-33993000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Year-over-year change in Operating cash flow: -12115000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -33993000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707 Input fundies:OperatingCashFlow: -21878000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+38.5%

Prior period

USD 327,000

2006-01-01 – 2006-12-31
Current period

USD 453,000

2007-01-01 – 2007-12-31

Exact inputs and evidence

453000 − 327000 = 126000 USD

327000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
453000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Year-over-year change in Capital expenditure: 126000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 453000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860 Input fundies:CapitalExpenditure: 327000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 11.52 million 100% of revenue
Operating costs Derived USD 47.68 million 414% of revenue
Operating income −USD 36.16 million −314% of revenue
Tax, interest and other Derived −USD 874,000 −7.6% of revenue
Net income −USD 35.29 million −306% of revenue

Cash

Operating cash flow −USD 33.99 million −295% of revenue
Capital expenditure USD 453,000 3.9% of revenue
Free cash flow Derived −USD 34.45 million −299% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 2,235% of revenue.
2003 Operating loss: operating costs were 390% of revenue.
2004 Operating loss: operating costs were 351% of revenue.
2005 Operating loss: operating costs were 379% of revenue.
2006 Operating loss: operating costs were 453% of revenue.
2007 Operating loss: operating costs were 414% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	1183000	26440000 Derived	-25257000	-94000 Derived	-25163000	-18779000 Derived	Source 2002-01-01 – 2002-12-31: 1183000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -25257000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -25163000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -14615000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 4164000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	7618000	29737000 Derived	-22119000	-333000 Derived	-21786000	-9468000 Derived	Source 2003-01-01 – 2003-12-31: 7618000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -22119000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -21786000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -7376000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 2092000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	9780000	34368000 Derived	-24588000	-492000 Derived	-24096000	-24358000 Derived	Source 2004-01-01 – 2004-12-31: 9780000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -24588000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -24096000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -21017000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3341000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	11111000	42127000 Derived	-31016000	670000 Derived	-31686000	-26484000 Derived	Source 2005-01-01 – 2005-12-31: 11111000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -31016000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -31686000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -25515000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 969000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	9322000	42244000 Derived	-32922000	-1815000 Derived	-31107000	-22205000 Derived	Source 2006-01-01 – 2006-12-31: 9322000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -32922000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -31107000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -21878000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 327000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	11519000	47678000 Derived	-36159000	-874000 Derived	-35285000	-34446000 Derived	Source 2007-01-01 – 2007-12-31: 11519000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -36159000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -35285000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -33993000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 453000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11.5M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	1183000	Revenue: 1183000 Open source
20032003-12-31	Revenue	7618000	Revenue: 7618000 Open source
20042004-12-31	Revenue	9780000	Revenue: 9780000 Open source
20052005-12-31	Revenue	11111000	Revenue: 11111000 Open source
20062006-12-31	Revenue	9322000	Revenue: 9322000 Open source
20072007-12-31	Revenue	11519000	Revenue: 11519000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

23.6% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 1183000 Open source
20032003-12-31	Year over year	544%	Revenue: 7618000 Open source Revenue: 1183000 Open source
20042004-12-31	Year over year	28.4%	Revenue: 9780000 Open source Revenue: 7618000 Open source
20052005-12-31	Year over year	13.6%	Revenue: 11111000 Open source Revenue: 9780000 Open source
20062006-12-31	Year over year	-16.1%	Revenue: 9322000 Open source Revenue: 11111000 Open source
20072007-12-31	Year over year	23.6%	Revenue: 11519000 Open source Revenue: 9322000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -313.9% 2007

Net margin -306.3% 2007

Free cash flow margin -299% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	-2,135%	Operating Income: -25257000 Open source Revenue: 1183000 Open source
20032003-12-31	Operating margin	-290.4%	Operating Income: -22119000 Open source Revenue: 7618000 Open source
20042004-12-31	Operating margin	-251.4%	Operating Income: -24588000 Open source Revenue: 9780000 Open source
20052005-12-31	Operating margin	-279.1%	Operating Income: -31016000 Open source Revenue: 11111000 Open source
20062006-12-31	Operating margin	-353.2%	Operating Income: -32922000 Open source Revenue: 9322000 Open source
20072007-12-31	Operating margin	-313.9%	Operating Income: -36159000 Open source Revenue: 11519000 Open source
20022002-12-31	Net margin	-2,127%	Net Income: -25163000 Open source Revenue: 1183000 Open source
20032003-12-31	Net margin	-286%	Net Income: -21786000 Open source Revenue: 7618000 Open source
20042004-12-31	Net margin	-246.4%	Net Income: -24096000 Open source Revenue: 9780000 Open source
20052005-12-31	Net margin	-285.2%	Net Income: -31686000 Open source Revenue: 11111000 Open source
20062006-12-31	Net margin	-333.7%	Net Income: -31107000 Open source Revenue: 9322000 Open source
20072007-12-31	Net margin	-306.3%	Net Income: -35285000 Open source Revenue: 11519000 Open source
20022002-12-31	Free cash flow margin	-1,587.4%	Revenue: 1183000 Open source Operating Cash Flow: -14615000 Open source Capital Expenditure: 4164000 Open source
20032003-12-31	Free cash flow margin	-124.3%	Revenue: 7618000 Open source Operating Cash Flow: -7376000 Open source Capital Expenditure: 2092000 Open source
20042004-12-31	Free cash flow margin	-249.1%	Revenue: 9780000 Open source Operating Cash Flow: -21017000 Open source Capital Expenditure: 3341000 Open source
20052005-12-31	Free cash flow margin	-238.4%	Revenue: 11111000 Open source Operating Cash Flow: -25515000 Open source Capital Expenditure: 969000 Open source
20062006-12-31	Free cash flow margin	-238.2%	Revenue: 9322000 Open source Operating Cash Flow: -21878000 Open source Capital Expenditure: 327000 Open source
20072007-12-31	Free cash flow margin	-299%	Revenue: 11519000 Open source Operating Cash Flow: -33993000 Open source Capital Expenditure: 453000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -34M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-14615000	Operating Cash Flow: -14615000 Open source
20032003-12-31	Operating cash flow	-7376000	Operating Cash Flow: -7376000 Open source
20042004-12-31	Operating cash flow	-21017000	Operating Cash Flow: -21017000 Open source
20052005-12-31	Operating cash flow	-25515000	Operating Cash Flow: -25515000 Open source
20062006-12-31	Operating cash flow	-21878000	Operating Cash Flow: -21878000 Open source
20072007-12-31	Operating cash flow	-33993000	Operating Cash Flow: -33993000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -34.4M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-18779000	Operating Cash Flow: -14615000 Open source Capital Expenditure: 4164000 Open source
20032003-12-31	Free cash flow	-9468000	Operating Cash Flow: -7376000 Open source Capital Expenditure: 2092000 Open source
20042004-12-31	Free cash flow	-24358000	Operating Cash Flow: -21017000 Open source Capital Expenditure: 3341000 Open source
20052005-12-31	Free cash flow	-26484000	Operating Cash Flow: -25515000 Open source Capital Expenditure: 969000 Open source
20062006-12-31	Free cash flow	-22205000	Operating Cash Flow: -21878000 Open source Capital Expenditure: 327000 Open source
20072007-12-31	Free cash flow	-34446000	Operating Cash Flow: -33993000 Open source Capital Expenditure: 453000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

82.2% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Liabilities / assets	Not reported	No source recorded
20032003-12-31	Liabilities / assets	65.9%	Total Liabilities: 28616000 Open source Total Assets: 43434000 Open source
20042004-12-31	Liabilities / assets	48.6%	Total Liabilities: 25955000 Open source Total Assets: 53397000 Open source
20052005-12-31	Liabilities / assets	62.8%	Total Liabilities: 35362000 Open source Total Assets: 56313000 Open source
20062006-12-31	Liabilities / assets	61.7%	Total Liabilities: 37440000 Open source Total Assets: 60642000 Open source
20072007-12-31	Liabilities / assets	82.2%	Total Liabilities: 38243000 Open source Total Assets: 46510000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.3× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Current assets / current liabilities	Not reported	No source recorded
20032003-12-31	Current assets / current liabilities	2.65×	Current Assets: 33790000 Open source Current Liabilities: 12752000 Open source
20042004-12-31	Current assets / current liabilities	3.09×	Current Assets: 42509000 Open source Current Liabilities: 13769000 Open source
20052005-12-31	Current assets / current liabilities	3.17×	Current Assets: 46641000 Open source Current Liabilities: 14698000 Open source
20062006-12-31	Current assets / current liabilities	3.64×	Current Assets: 52720000 Open source Current Liabilities: 14465000 Open source
20072007-12-31	Current assets / current liabilities	3.3×	Current Assets: 39618000 Open source Current Liabilities: 12021000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 25.16 million Exact value Exact value: -25163000 USD 2002-01-01 – 2002-12-31: -25163000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2002-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -25163000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25163000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-05-003936.txt#9721 The citation records this snapshot. The page link may show a newer release later.	−USD 14.62 million Exact value Exact value: -14615000 USD 2002-01-01 – 2002-12-31: -14615000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2002-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -14615000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14615000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-05-003936.txt#9898 The citation records this snapshot. The page link may show a newer release later.	USD 4.16 million Exact value Exact value: 4164000 USD 2002-01-01 – 2002-12-31: 4164000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2002-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 4164000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4164000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-05-003936.txt#9970 The citation records this snapshot. The page link may show a newer release later.	−USD 18.78 million Calculation and evidence -14615000 − 4164000 USD Exact free cash flow: -18779000 USD 2002-01-01 – 2002-12-31: -14615000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 4164000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2002-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -18779000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14615000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-05-003936.txt#9898 Input fundies:CapitalExpenditure: 4164000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-05-003936.txt#9970 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 21.79 million Exact value Exact value: -21786000 USD 2003-01-01 – 2003-12-31: -21786000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2003-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -21786000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21786000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-06-004010.txt#10095 The citation records this snapshot. The page link may show a newer release later.	−USD 7.38 million Exact value Exact value: -7376000 USD 2003-01-01 – 2003-12-31: -7376000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2003-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -7376000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7376000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-06-004010.txt#10303 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2092000 USD 2003-01-01 – 2003-12-31: 2092000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2003-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 2092000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2092000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-06-004010.txt#10375 The citation records this snapshot. The page link may show a newer release later.	−USD 9.47 million Calculation and evidence -7376000 − 2092000 USD Exact free cash flow: -9468000 USD 2003-01-01 – 2003-12-31: -7376000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 2092000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2003-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -9468000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7376000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-06-004010.txt#10303 Input fundies:CapitalExpenditure: 2092000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000950123-06-004010.txt#10375 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 24.1 million Exact value Exact value: -24096000 USD 2004-01-01 – 2004-12-31: -24096000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2004-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -24096000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24096000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6175 The citation records this snapshot. The page link may show a newer release later.	−USD 21.02 million Exact value Exact value: -21017000 USD 2004-01-01 – 2004-12-31: -21017000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2004-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -21017000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21017000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6371 The citation records this snapshot. The page link may show a newer release later.	USD 3.34 million Exact value Exact value: 3341000 USD 2004-01-01 – 2004-12-31: 3341000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2004-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 3341000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3341000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6441 The citation records this snapshot. The page link may show a newer release later.	−USD 24.36 million Calculation and evidence -21017000 − 3341000 USD Exact free cash flow: -24358000 USD 2004-01-01 – 2004-12-31: -21017000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3341000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2004-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -24358000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21017000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6371 Input fundies:CapitalExpenditure: 3341000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6441 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 31.69 million Exact value Exact value: -31686000 USD 2005-01-01 – 2005-12-31: -31686000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2005-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -31686000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31686000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6175 The citation records this snapshot. The page link may show a newer release later.	−USD 25.52 million Exact value Exact value: -25515000 USD 2005-01-01 – 2005-12-31: -25515000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2005-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -25515000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25515000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6371 The citation records this snapshot. The page link may show a newer release later.	USD 969,000 Exact value Exact value: 969000 USD 2005-01-01 – 2005-12-31: 969000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2005-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 969000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 969000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6441 The citation records this snapshot. The page link may show a newer release later.	−USD 26.48 million Calculation and evidence -25515000 − 969000 USD Exact free cash flow: -26484000 USD 2005-01-01 – 2005-12-31: -25515000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 969000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2005-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -26484000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25515000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6371 Input fundies:CapitalExpenditure: 969000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0001193125-07-070883.txt#6441 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 31.11 million Exact value Exact value: -31107000 USD 2006-01-01 – 2006-12-31: -31107000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2006-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -31107000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31107000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16212 The citation records this snapshot. The page link may show a newer release later.	−USD 21.88 million Exact value Exact value: -21878000 USD 2006-01-01 – 2006-12-31: -21878000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2006-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -21878000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21878000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707 The citation records this snapshot. The page link may show a newer release later.	USD 327,000 Exact value Exact value: 327000 USD 2006-01-01 – 2006-12-31: 327000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2006-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 327000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 327000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860 The citation records this snapshot. The page link may show a newer release later.	−USD 22.21 million Calculation and evidence -21878000 − 327000 USD Exact free cash flow: -22205000 USD 2006-01-01 – 2006-12-31: -21878000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 327000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2006-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -22205000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21878000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707 Input fundies:CapitalExpenditure: 327000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 35.29 million Exact value Exact value: -35285000 USD 2007-01-01 – 2007-12-31: -35285000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Net Income: -35285000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35285000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16212 The citation records this snapshot. The page link may show a newer release later.	−USD 33.99 million Exact value Exact value: -33993000 USD 2007-01-01 – 2007-12-31: -33993000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Operating Cash Flow: -33993000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33993000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707 The citation records this snapshot. The page link may show a newer release later.	USD 453,000 Exact value Exact value: 453000 USD 2007-01-01 – 2007-12-31: 453000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Capital Expenditure: 453000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 453000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860 The citation records this snapshot. The page link may show a newer release later.	−USD 34.45 million Calculation and evidence -33993000 − 453000 USD Exact free cash flow: -34446000 USD 2007-01-01 – 2007-12-31: -33993000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 453000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEMORY PHARMACEUTICALS CORP · 2007-12-31 MEMORY PHARMACEUTICALS CORP (edgar:1062216) Free cash flow: -34446000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:59:59Z Snapshot: eac42ba74c6154cb13be7c984cfc0e990db6b491cd7dac1552649dd203e0dbad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1062216?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33993000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16707 Input fundies:CapitalExpenditure: 453000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1062216/0000893220-08-000895.txt#16860 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

21 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001062216, 1062216, edgar:1062216

MEMORY PHARMACEUTICALS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation